Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Expression profiles of HepG2 cells treated with low-, high-dose of acetaminophen and solvent control
PubMed Similar studies Analyze with GEO2R
Evaluation of the robustness of classification of carcinogen-modified transcriptomic responses in HepaRG cells and the interlaboratory reproducibility of the model
Analyze with GEO2R
Analyses of transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models
Comparison of Gene expression profiles between myometrium, MED12 mutation positive uterine leiomyomas and MED12 wildtype uterine leiomyomas
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array [CDF: Brainarray ENSG Version 14.1]
HepG2_0.5_%_DMSO_3_72h_rep3
HepG2_0.5_%_DMSO_3_72h_rep2
HepG2_0.5_%_DMSO_3_72h_rep1
HepG2_500_µM_Acetominophen_72h_rep3
HepG2_500_µM_Acetominophen_72h_rep2
HepG2_500_µM_Acetominophen_72h_rep1
HepG2_10000_µM_Acetominophen_72h_rep3
HepG2_10000_µM_Acetominophen_72h_rep2
HepG2_10000_µM_Acetominophen_72h_rep1
HepG2_0.5_%_DMSO_3_48h_rep3
HepG2_0.5_%_DMSO_3_48h_rep2
HepG2_0.5_%_DMSO_3_48h_rep1
HepG2_500_µM_Acetominophen_48h_rep3
HepG2_500_µM_Acetominophen_48h_rep2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on